Hypolipidemic effect of arthrospira (spirulina) maxima supplementation and a systematic physical exercise program in overweight and obese men: A double-blind, randomized, and crossover controlled trial

Marine Drugs

Volumn 17, Issue 5, 2019, Pages

  Hernández Lepe, Marco Antonio ^a   Wall Medrano, Abraham ^b   López Díaz, José Alberto ^b   Juárez Oropeza, Marco Antonio ^c   Luqueño Bocardo, Oscar Iván ^c   Hernández Torres, Rosa Patricia ^d   Ramos Jiménez, Arnulfo ^b  

^a UNIVERSIDAD AUTÓNOMA DE BAJA CALIFORNIA   (Mexico)

^b UNIVERSIDAD AUTÓNOMA DE CIUDAD JUÁREZ   (Mexico)

^c UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^d UNIVERSIDAD AUTÓNOMA DE CHIHUAHUA   (Mexico)

Author keywords

Arthrospira maxima; Double blind; Dyslipidemia; Obesity; Physical exercise; Randomized controlled trial

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; SPIRULINA EXTRACT; TRIACYLGLYCEROL; CHOLESTEROL; LIPID;

ADULT; AEROBIC EXERCISE; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DYSLIPIDEMIA; HIGH INTENSITY INTERVAL TRAINING; HUMAN; MAJOR CLINICAL STUDY; MALE; OBESITY; RANDOMIZED CONTROLLED TRIAL; BLOOD; BODY WEIGHT; DIET; DIETARY SUPPLEMENT; DRUG EFFECT; EXERCISE; METABOLISM; SPIRULINA;

ADULT; BODY MASS INDEX; BODY WEIGHT; CHOLESTEROL; CHOLESTEROL, HDL; CHOLESTEROL, LDL; CROSS-OVER STUDIES; DIET; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; DYSLIPIDEMIAS; EXERCISE; HUMANS; LIPIDS; MALE; OBESITY; OVERWEIGHT; SPIRULINA; TRIGLYCERIDES;

EID: 85065767923     PISSN: None     EISSN: 16603397     Source Type: Journal    
DOI: 10.3390/md17050270     Document Type: Article

References (47)

1. Smith, S.C.; Collins, A.; Ferrari, R.; Holmes, D.R.; Logstrup, S.; Vaca, D.; Ralston, J.; Sacco, R.L.; Stam, H.; Taubert, K.; et al. Our time: A call to save preventable death from cardiovascular disease (heart disease and stroke). J. Am. Coll. Cardiol. 2012, 60, 2343-2348.
2. D'Adamo, E.; Guardamagna, O.; Chiarelli, F.; Bartuli, A.; Liccardo, D.; Ferrari, F.; Nobili, V. Atherogenic dyslipidemia and cardiovascular risk factors in obese children. Int. J. Endocrinol. 2015, 2015.
3. Wall-Medrano, A.; Ramos-Jiménez, A.; Hernández-Torres, R.P.; Villalobos-Molina, R.; Tapia-Pancardo, D.C.; Jiménez-Flores, J.R.; Méndez-Cruz, A.R.; Murguía-Romero, M.; Gallardo-Ortíz, I.A.; Urquídez-Romero, R. Cardiometabolic risk in young adults from northern Mexico: Revisiting body mass index and waist-circumference as predictors. BMC Public Health 2016, 16, 236.
4. Ross, R.; Hudson, R.; Stotz, P.J.; Lam, M. Effects of exercise amount and intensity on abdominal obesity and glucose tolerance in obese adults: a randomized trial. Ann. Intern. Med. 2015, 162, 325-334.
5. Greene, N.P.; Martin, S.E.; Crouse, S.F. Acute exercise and training alter blood lipid and lipoprotein profiles differently in overweight and obese men and women. Obesity 2012, 20, 1618-1627.
6. Shaw, K.A.; Gennat, H.C.; O'Rourke, P.; Del Mar, C. Exercise for overweight or obesity. Cochrane Db. Syst. Rev. 2006, 4, CD003817.
7. Shiraev, T.; Barclay, G. Evidence based exercise: Clinical benefits of high intensity interval training. Aust. Fam. Physician 2012, 41, 960.
8. Chen, G.; Wang, H.; Zhang, X.; Yang, S.-T. Nutraceuticals and functional foods in the management of hyperlipidemia. Crit. Rev. Food Sci. Nutr. 2014, 54, 1180-1201.
9. Mimouni, V.; Ulmann, L.; Haimeur, A.; Guéno, F.; Meskini, N.; Tremblin, G. Marine microalgae used as food supplements and their implication in preventing cardiovascular diseases. OCL 2015, 22, D409.
10. Tomé-Carneiro, J.; Visioli, F. Polyphenol-based nutraceuticals for the prevention and treatment of cardiovascular disease: Review of human evidence. Phytomedicine 2016, 23, 1145-1174.
11. Memije-Lazaro, I.N.; Blas-Valdivia, V.; Franco-Colín, M.; Cano-Europa, E. Arthrospira maxima (Spirulina) and C-phycocyanin prevent the progression of chronic kidney disease and its cardiovascular complications. J. Funct. Food 2018, 43, 37-43.
12. Moura, L.P.; Puga, G.M.; Beck, W.R.; Teixeira, I.P.; Ghezzi, A.C.; Silva, G.A.; Mello, M.A.R. Exercise and spirulina control non-alcoholic hepatic steatosis and lipid profile in diabeticWistar rats. Lipids Health Dis. 2011, 10, 77.
13. Mazzola, D.; Fornari, F.; Vigano, G.; Oro, T.; Costa, J.A.V.; Bertolin, T.E. Spirulina platensis Enhances the beneficial effect of exercise on oxidative stress and the lipid profile in rats. Braz. Arch. Biol. Techn. 2015, 58, 961-969.
14. Kata, F.S.; Athbi, A.M.; Manwar, E.Q.; Al-Ashoor, A.; Abdel-Daim, M.M.; Aleya, L. Therapeutic effect of the alkaloid extract of the cyanobacterium Spirulina platensis on the lipid profile of hypercholesterolemic male rabbits. Environ. Sci. Pollut. Res. Int. 2018, 25, 19635-19642.
15. Must, A.; Spadano, J.; Coakley, E.H.; Field, A.E.; Colditz, G.; Dietz, W.H. The disease burden associated with overweight and obesity. JAMA 1999, 282, 1523-1529.
16. Wilborn, C.; Beckham, J.; Campbell, B.; Harvey, T.; Galbreat, M.; La Bounty, P.; Nassar, E.; Wismann, J.; Kreider, R. Obesity: prevalence, theories, medical consequences, management, and research directions. J. Int. Soc. Sport. Nutr. 2005, 2, 4.
17. Mani, U.V.; Desai, S.; Iyer, U. Studies on the long-term effect of spirulina supplementation on serum lipid profile and glycated proteins in NIDDM patients. J. Nutraceuticals Funct. Med. Food 2000, 2, 25-32.
18. Lee, E.H.; Park, J.E.; Choi, Y.J.; Huh, K.B.; Kim, W.Y. A randomized study to establish the effects of spirulina in type 2 diabetes mellitus patients. Nutr. Res. Pract. 2008, 2, 295-300.
19. Kalafati, M.; Jamurtas, A.Z.; Nikolaidis, M.G.; Paschalis,V.; Theodorou, A.A.; Sakellariou, G.K.; Koutedakis, Y.; Kouretas, D. Ergogenic and antioxidant effects of spirulina supplementation in humans. Med. Sci. Sports Exerc. 2010, 42, 142-151.
20. Iwata, K.; Inayama, T.; Kato, T. Effects of Spirulina platensis on plasma lipoprotein lipase activity in fructose-induced hyperlipidemic rats. J. Nutr. Sci. Vitaminol. 1990, 36, 165-171.
21. Upasani, C.D.; Balaraman, R. Protective effect of Spirulina on lead induced deleterious changes in the lipid peroxidation and endogenous antioxidants in rats. Phytother. Res. 2003, 17, 330-334.
22. Sharma, N.K.; Tiwari, S.P.; Tripathi, K.; Rai, A.K. Sustainability and cyanobacteria (blue-green algae): facts and challenges. Appl. Phycol. 2011, 23, 1059-1081.
23. Nagaoka, S.; Shimizu, K.; Kaneko, H.; Shibayama, F.; Morikawa, K.; Kanamaru, Y.; Otsuka, A.; Hirahashi, T.; Kato, T. A novel protein C-phycocyanin plays a crucial role in the hypocholesterolemic action of Spirulina platensis concentrate in rats. J. Nutr. 2005, 135, 2425-2430.
24. Chen, Z.Y.; Jiao, R.; Ma, K.Y. Cholesterol-lowering nutraceuticals and functional foods. J. Agric. Food Chem. 2008, 56, 8761-8773.
25. Thompson, P.D.; Clarkson, P.; Karas, R.H. Statin-associated myopathy. JAMA 2003, 289, 1681-1690.
26. Gao, L.; Lin, Z.; Liu, Y.;Wang, X.;Wan, L.; Zhang, L.; Liu, X. Hypolipidemic effect of Fragarianilgerrensis Schlecht. medicine compound on hyperlipidemic rats. Lipids Health Dis. 2018, 17, 222.
27. Kraus, W.E.; Houmard, J.A.; Duscha, B.D.; Knetzger, K.J.; Wharton, M.B.; McCartney, J.S.; Bales, C.W.; Henes, S.; Samsa, G.P.; Otvos, J.D.; et al. Effects of the amount and intensity of exercise on plasma lipoproteins. N. Engl. J. Med. 2002, 347, 1483-1492.
28. Oscai, L.B.; Essig, D.A.; Palmer,W.K. Lipase regulation of muscle triglyceride hydrolysis. J. Appl. Physiol. 1990, 69, 1571-1577.
29. Nikolaidis, M.G.; Paschalis, V.; Giakas, G.; Fatouros, I.G.; Sakellariou, G.K.; Theodorou, A.A.; Koutedakis, Y.; Jamurtas, A.Z. Favorable and prolonged changes in blood lipid profile after muscle-damaging exercise. Med. Sci. Sports Exerc. 2008, 40, 1483-1489.
30. Tan, S.; Wang, J.; Cao, L.; Guo, Z.; Wang, Y. Positive effect of exercise training at maximal fat oxidation intensity on body composition and lipid metabolism in overweight middle-aged women. Clin. Physiol. Funct. Imaging 2016, 36, 225-230.
31. Cugusi, L.; Cadeddu, C.; Nocco, S.; Orrù, F.; Bandino, S.; Deidda, M.; Caria, A.; Bassareo, P.P.; Piras, A.; Cabras, S.; et al. Effects of an aquatic-based exercise program to improve cardiometabolic profile, quality of life, and physical activity levels in men with type 2 diabetes mellitus. PM R 2015, 7, 141-148.
32. Kelley, G.A.; Kelley, K.S.; Tran, Z.V. Aerobic exercise, lipids and lipoproteins in overweight and obese adults: a meta-analysis of randomized controlled trials. Int. J. Obes. 2005, 29, 881.
33. Hernández-Lepe, M.; López-Díaz, J.; Juárez-Oropeza, M.; Hernández-Torres, R.P.; Wall-Medrano, A.; Ramos-Jiménez, A. Effect of Arthrospira (Spirulina) maxima Supplementation and a Systematic Physical Exercise Program on the Body Composition and Cardiorespiratory Fitness of Overweight or Obese Subjects: A Double-Blind, Randomized, and Crossover Controlled Trial. Mar. Drugs. 2018, 16, 364.
34. Nguyen, N.T.; Magno, C.P.; Lane, K.T.; Hinojosa, M.W.; Lane, J.S. Association of hypertension, diabetes, dyslipidemia, and metabolic syndrome with obesity: Findings from the national health and nutrition examination survey, 1999 to 2004. J. Am. Coll. Surg. 2008, 207, 928-934.
35. He, J.; Watkins, S.; Kelley, D.E. Skeletal muscle lipid content and oxidative enzyme activity in relation to muscle fiber type in type 2 diabetes and obesity. Diabetes 2001, 50, 817-823.
36. Goodpaster, B.H.;Wolfe, R.R.; Kelley, D.E. Effects of obesity on substrate utilization during exercise. Obes. Res. 2002, 10, 575-584.
37. Das, U.N.; Rao, A.A. Gene expression profile in obesity and type 2 diabetes mellitus. Lipids Health Dis. 2007, 6, 35.
38. Baothman, O.A.; Zamzami, M.A.; Taher, I.; Abubaker, J.; Abu-Farha, M. The role of gut microbiota in the development of obesity and diabetes. Lipids Health Dis. 2016, 15, 108.
39. Hernández-Lepe, M.A.; López-Díaz, J.A.; de la Rosa, L.A.; Hernández-Torres, R.P.; Wall-Medrano, A.; Juarez-Oropeza, M.A.; Pedraza-Chaverri, J.; Urquidez-Romero, R.; Ramos-Jiménez, A. Double-blind randomised controlled trial of the independent and synergistic effect of Spirulina maxima with exercise (ISESE) on general fitness, lipid profile and redox status in overweight and obese subjects: Study protocol. BMJ Open 2017, 7, 013744.
40. Schulz, K.F.; Grimes, D.A. Generation of allocation sequences in randomised trials: Chance, not choice. Lancet 2002, 359, 515-519.
41. Faul, F.; Erdfelder, E.; Lang, A.G.; Buchner, A. G Power 3: A flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav. Res. Methods. 2007, 39, 175-191.
42. Hernández-Lepe, M.A.;Wall-Medrano, A.; Juárez-Oropeza, M.A.; Ramos-Jiménez, A.; Hernández-Torres, R.P. Spirulina y su efecto hipolipemiante y antioxidante en humanos: una revisión sistemática. Nutr. Hosp. 2015, 32, 494-500.
43. Friedewald,W.T.; Levy, R.I.; Fredrickson, D.S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin. Chem. 1972, 18, 499-502.
44. Nelson, M. The validation of dietary assessment. In Design Concepts in Nutritional Epidemiology, 2nd ed.; Margetts, B.M., Nelson, M., Eds.; Oxford University Press: Oxford, UK, 1997; pp. 266-295.
45. American College of Sports Medicine. ACSM's Guidelines for Exercise Testing and Prescription, 10th ed.; LippincottWilliams &Wilkins: Philadelphia, PA, USA, 2016; pp. 111-142.
46. Swain, D.P.; Leutholtz, B.C. Heart rate reserve is equivalent to% VO2 reserve, not to% VO2max. Med. Sci. Sports Exerc. 1997, 29, 410-414.
47. Meydani, M.; Hasan, S.T. Dietary polyphenols and obesity. Nutrients 2010, 2, 737-751.